<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:05:50Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5543122" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5543122</identifier><datestamp>2017-08-09</datestamp><setSpec>ncomms</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Commun</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id>
      <journal-title-group>
        <journal-title>Nature Communications</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2041-1723</issn>
      <publisher>
        <publisher-name>Nature Publishing Group UK</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5543122</article-id>
      <article-id pub-id-type="pmcid">PMC5543122</article-id>
      <article-id pub-id-type="pmc-uid">5543122</article-id>
      <article-id pub-id-type="pmid">28775322</article-id>
      <article-id pub-id-type="publisher-id">255</article-id>
      <article-id pub-id-type="doi">10.1038/s41467-017-00255-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Structural basis of Notch O-glucosylation and Oâxylosylation by mammalian proteinâO-glucosyltransferase 1 (POGLUT1)</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9283-6072</contrib-id>
          <name>
            <surname>Li</surname>
            <given-names>Zhijie</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fischer</surname>
            <given-names>Michael</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Satkunarajah</surname>
            <given-names>Malathy</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>Dongxia</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Withers</surname>
            <given-names>Stephen G.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Rini</surname>
            <given-names>James M.</given-names>
          </name>
          <address>
            <email>james.rini@utoronto.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id><institution-id institution-id-type="GRID">grid.17063.33</institution-id><institution>Department of Biochemistry, </institution><institution>University of Toronto, </institution></institution-wrap>Toronto, ON Canada M5S 1A8 </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id><institution-id institution-id-type="GRID">grid.17063.33</institution-id><institution>Department of Molecular Genetics, </institution><institution>University of Toronto, </institution></institution-wrap>Toronto, ON Canada M5S 1A8 </aff>
        <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2288 9830</institution-id><institution-id institution-id-type="GRID">grid.17091.3e</institution-id><institution>Department of Chemistry, </institution><institution>University of British Columbia, </institution></institution-wrap>Vancouver, BC Canada V6T 1Z1 </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>4</day>
        <month>8</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>4</day>
        <month>8</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <volume>8</volume>
      <elocation-id>185</elocation-id>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>7</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>6</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© The Author(s) 2017</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the articleâs Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the articleâs Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p id="Par1">Protein <italic>O</italic>-glucosyltransferase 1/Rumi-mediated glucosylation of Notch epidermal growth factor-like (EGF-like) domains plays an important role in Notch signaling. Protein <italic>O</italic>-glucosyltransferase 1 shows specificity for folded EGF-like domains, it can only glycosylate serine residues in the C<sup>1</sup>X<underline>S</underline>XPC<sup>2</sup> motif, and it possesses an uncommon dual donor substrate specificity. Using several EGF-like domains and donor substrate analogs, we have determined the structures of human Protein <italic>O</italic>-glucosyltransferase 1 substrate/product complexes that provide mechanistic insight into the basis for these properties. Notably, we show that Protein <italic>O</italic>-glucosyltransferase 1âs requirement for folded EGF-like domains also leads to its serine specificity and that two distinct local conformational states are likely responsible for its ability to transfer both glucose and xylose. We also show that Protein <italic>O</italic>-glucosyltransferase 1 possesses the potential to xylosylate a much broader range of EGF-like domain substrates than was previously thought. Finally, we show that Protein <italic>O</italic>-glucosyltransferase 1 has co-evolved with EGF-like domains of the type found in Notch.</p>
      </abstract>
      <abstract id="Abs2" abstract-type="web-summary">
        <p id="Par2">POGLUT1 is a protein-O-glucosyltransferase that transfers glucose and xylose to the EGF-like domains of Notch and other signaling receptors. Here the authors report the structure of human POGLUT1 in complexes with 3 different EGF-like domains and donor substrates and shed light on the enzymeâs substrate specificity and catalytic mechanism</p>
      </abstract>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>Â© The Author(s) 2017</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p id="Par3">Protein <italic>O</italic>-glucosyltransferase 1 (POGLUT1) glucosylates the epidermal growth factor-like (EGF-like) domains found in diverse substrates including Notch and its ligands<sup><xref ref-type="bibr" rid="CR1">1</xref>â<xref ref-type="bibr" rid="CR3">3</xref></sup> (Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>a). Including work done on its <italic>Drosophila</italic> homolog, Rumi<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>, it has been well established that <italic>O</italic>-glucosylation by this enzyme is critical for development and Notch signaling<sup><xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR4">4</xref></sup>. More recently, the action of POGLUT1/Rumi on the Eyes shut protein was shown to promote rhabdomere separation in <italic>Drosophila</italic>
<sup><xref ref-type="bibr" rid="CR5">5</xref></sup> and its action on the mammalian Crumbs2 protein was shown to promote mouse gastrulation<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. In humans, defects in POGLUT1 have been found to cause DowlingâDegos disease<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> and a form of limb-girdle muscular dystrophy associated with decreased Notch signaling<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Like the EGF-like domain <italic>O</italic>-fucosylation enzyme POFUT1<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>, POGLUT1 only acts on folded EGF-like domains<sup><xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR10">10</xref></sup>, a property thought to reflect a role in protein folding and/or quality control<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. Indeed, glucosylation by Rumi has varying effects on the folding, thermal stability, and trafficking/secretion of Notch, Crumbs, and Eyes shut<sup><xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref></sup>. Unlike most other glycosyltransferases, POGLUT1 displays dual donor substrate specificity as it can utilize both UDP-glucose and UDP-xylose, a property leading to the incorporation of both xylose and glucose into Notch proteins<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. Moreover, unlike other protein-<italic>O</italic>-glycosyltransferases that modify both serine and threonine, POGLUT1 can only utilize serine<sup><xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR15">15</xref></sup>. Recently, structures of <italic>Drosophila</italic> Rumi (dRumi) in complex with human Factor IX EGF-like domain 1 (hF9EGF1) and UDP have provided insight into EGF-like domain recognition and the possible effects of disease causing mutations<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>.<fig id="Fig1"><label>Fig. 1</label><caption><p>The overall structure of the POGLUT1-EGF complexes. <bold>a</bold> POGLUT1 catalyzes the transfer of a glucose moiety (<italic>blue circle</italic>) to EGF-like domains (<italic>red box</italic>) containing the <italic>O</italic>-glucosylation motif C<sup>1</sup>XaSXbPC<sup>2</sup>. Human proteins with 10 or more <italic>O</italic>-glucosylation sites are shown. <bold>b</bold> The POGLUT1/hEGF12/UDP complex with POGLUT1 shown in ribbon representation. <italic>Orange</italic>, residues 30â169, <italic>blue</italic>, residues 170â385. The N-terminal and C-terminal segments each insert into the opposite domain. <bold>c</bold> The three co-crystallized EGF-like domains structurally aligned on POGLUT1: <italic>pink</italic>, EGF(+); <italic>cyan</italic>, hF7EGF1; <italic>ivory</italic>, hEGF12. <bold>d</bold> Conserved surface of POGLUT1. <italic>Deeper redness</italic> indicates higher conservation. <bold>e</bold> EGF-like domain-contacting surface (<italic>blue</italic>) of POGLUT1. <bold>f</bold> Comparison of POGLUT1-contacting surface (<italic>red surface</italic>, <italic>left</italic>) and location of the cysteine-delimited segments (<italic>right</italic>) of EGF(+). <bold>g</bold> EGF-like domain residue numbering. <italic>Gray lines</italic> show the three conserved disulfide bonds. Residues in contact with POGLUT1 are shaded <italic>magenta</italic>. <bold>h</bold> A scheme summarizing the interactions found in the three EGF-like domain complexes. Buried surface areas upon complex formation are plotted above each residue as heights of the green bars. <italic>Red dots</italic> below residues indicate backbone interactions; <italic>blue dots</italic> indicate hydrogen bonds. The four <italic>arrow heads</italic> indicate residues making conserved hydrogen bonds (C<sup>2</sup> makes two of them). The Sequence logo at the top was generated from ~40,600 <italic>O</italic>-glucosylation motif-containing EGF-like domains found in 339 animal species. <bold>i</bold> Interactions of the EGF-like domain C<sup>4</sup>(â2)/C<sup>6</sup>(â2)/C<sup>6</sup>(â1) patch with POGLUT1 residues 103â105. The 170â181 and 238â242 loops and two residues making significant interactions with the EGF-like domains are also shown. <bold>j</bold> Locations of the 170â181 and 238â242 loops. <bold>k</bold> The burial of UDP (<italic>green</italic>) by the 170â181 loop (<italic>orange</italic>) and the EGF-like domain</p></caption><graphic xlink:href="41467_2017_255_Fig1_HTML" id="d29e512"/></fig>
</p>
      <p id="Par4">Here we report the structure of human POGLUT1 in complexes with three different EGF-like domains and either UDP, a donor substrate analog or a slow substrate. The structures reveal the basis for POGLUT1âs ability to recognize diverse EGF-like domain substrates and for the requirement that they be folded. We also show that POGLUT1âs serine specificity stems from the backbone conformation of the glycosylation motif and, as such, its requirement for a folded EGF-like domain substrate. POGLUT1 was found to access two local conformational states and we provide evidence to support the suggestion that they are individually responsible for the transfer of UDP-glucose and UDP-xylose. We also show that POGLUT1 does not require a diserine-containing glycosylation motif to efficiently xylosylate its substrates, an observation suggesting that it can xylosylate a much wider range of EGF-like domains than previously thought. Finally, we show that the POGLUT1 glycosylation motif is found predominantly among EGF-like domains of the type found in Notch and that POGLUT1 has co-evolved with these domains through animal evolution.</p>
    </sec>
    <sec id="Sec2" sec-type="results">
      <title>Results</title>
      <sec id="Sec3">
        <title>Overall structure of the hPOGLUT1âEGF-like domain complexes</title>
        <p id="Par5">The X-ray crystal structure of hPOGLUT1 was determined in complex with human factor VII EGF-like domain 1 (hF7EGF1) and human Notch1 EGF-like domain 12 (hEGF12), as well as a synthetic POGLUT1 substrate, EGF(+), the consensus sequence for human EGF-like domains that are POFUT1 substrates<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> (Supplementary TableÂ <xref rid="MOESM1" ref-type="media">1</xref>, Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">4</xref>). POGLUT1 is an inverting GT-B fold (CAZy GT Family 90<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>) glycosyltransferase and its EGF-like domain substrates sit in a cleft formed between the canonical N-terminal and C-terminal domains (Fig.Â <xref rid="Fig1" ref-type="fig">1b</xref>). The three EGF-like domains studied are positioned almost identically in their respective complexes and 25â30% of their surface (740â830âÃ<sup>2</sup>) is buried by POGLUT1 (Fig.Â <xref rid="Fig1" ref-type="fig">1c</xref>, Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">5</xref>). The interface between the EGF-like domains and POGLUT1 is highly complementary, with Sc scores<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> ranging from 0.75 to 0.80. Multiple points of contact and extensive buried surface clearly establish the basis for POGLUT1âs requirement for a folded EGF-like domain (Fig.Â <xref rid="Fig1" ref-type="fig">1dâf</xref>).</p>
        <p id="Par6">Three regions of the EGF-like domain are primarily responsible for the interaction with POGLUT1: (i) the C<sup>1</sup>C<sup>2</sup> loop that corresponds to the <italic>O</italic>-glucosylation motif (C<sup>1</sup>XaSXbPC<sup>2</sup>), (ii) the C<sup>2</sup>C<sup>3</sup> loop that is the site of the POFUT1 <italic>O</italic>-fucosylation motif (C<sup>2</sup>XXXXS/TC<sup>3</sup>), and (iii) a patch formed by residues C<sup>4</sup>(â2), C<sup>6</sup>(â1), and C<sup>6</sup>(â2) (Fig.Â <xref rid="Fig1" ref-type="fig">1f, g</xref>). The C<sup>1</sup>C<sup>2</sup> and C<sup>2</sup>C<sup>3</sup> loop interactions constitute ~38% and ~30%, respectively, of the EGF-like domain surface buried by POGLUT1 and are described in detail below. The C<sup>4</sup>(â2) residue is highly conserved among all animal EGF-like domains (Fig.Â <xref rid="Fig1" ref-type="fig">1h</xref>) and it is closely associated with the conserved proline residue of the glucosylation motif. Together these two residues make apolar interactions with POGLUT1 residues Met103, Phe104, and Pro105 (Fig.Â <xref rid="Fig1" ref-type="fig">1i</xref>) as is also observed for the equivalent residues in the dRumi-hF9EGF1 structure<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. The C<sup>6</sup>(â1) and C<sup>6</sup>(â2) residues, variable among EGF-like domains, also interact with Phe104 and Pro105. Among the complexes reported here, the interactions involving the C<sup>4</sup>(â2), C<sup>6</sup>(â1), and C<sup>6</sup>(â2) residues constitute 10â16% of the EGF-like domain surface buried on complex formation and POGLUT1 residues 103â105 constitute 18â20% of its buried surface.</p>
        <p id="Par7">Two POGLUT1 loops (Loop 1, 238â242; Loop 2, 170â181) constitute over 50% of the POGLUT1 surface area buried by the bound EGF-like domain. Loop 1 folds over the glucosylation motif (C<sup>1</sup>C<sup>2</sup> loop) of the EGF-like domain and Loop 2 interacts with the bound UDP/UDP-glucose and the C<sup>2</sup>C<sup>3</sup> loop. As such, Loop 2 is sandwiched between the donor and the acceptor substrates (Fig.Â <xref rid="Fig1" ref-type="fig">1iâk</xref>).</p>
      </sec>
      <sec id="Sec4">
        <title>POGLUT1 interactions with the <italic>O</italic>-glucosylation motif</title>
        <p id="Par8">The glucosylation motif (C<sup>1</sup>XaSXbPC<sup>2</sup>) is buried in a deep cleft where it is largely shielded from solvent (Fig.Â <xref rid="Fig2" ref-type="fig">2a</xref>), an indication of the key role that it plays in POGLUT1 recognition. Residues C<sup>1</sup>, Xa, Ser, and Xb belong to a short 3<sub>10</sub>-helix that is terminated by the conserved Pro and the residues centered on the Pro make the most intimate contacts with POGLUT1. Among the three different EGF-like domains studied, there are five hydrogen bonds between POGLUT1 and the EGF-like domain that are common and four of them involve invariant atoms of the glucosylation motif (Fig.Â <xref rid="Fig2" ref-type="fig">2c</xref>). Of these, three involve backbone atoms of residues Xb and C<sup>2</sup>, which are hydrogen bonded to POGLUT1 residues Gln240 and Ala172. The fourth is a strong hydrogen bond between the hydroxyl group of the glucosylatable serine residue and Asp133, the POGLUT1 catalytic base<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. The proline residue stabilizes the conformation required to make the observed backbone hydrogen bonds and it is sandwiched between POGLUT1 residues Phe104 and Gln240 (Fig.Â <xref rid="Fig2" ref-type="fig">2d</xref>). Of the two variable residues in the glucosylation motif (Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">3</xref>), Xa is relatively exposed and its sidechain is directed toward bulk solvent. In contrast, the Xb residue is largely buried by POGLUT1 residue Gln240. Of the EGF-like domains studied, hEGF12 and EGF(+) contain an asparagine residue at the Xb position (C<sup>1</sup>Xa<underline>S</underline>NPC<sup>2</sup>) while hF7EGF1 contains a serine (C<sup>1</sup>Xa<underline>S</underline>SPC<sup>2</sup>). In all cases, the asparagine and serine sidechains make a strong hydrogen bond to the backbone NH group of Gln240 (Fig.Â <xref rid="Fig2" ref-type="fig">2b</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Recognition of the C<sup>1</sup>C<sup>2</sup> and C<sup>2</sup>C<sup>3</sup> loops. <bold>a</bold> The C<sup>1</sup>C<sup>2</sup> loop (<italic>orange</italic>) is buried in POGLUT1. <bold>b</bold> Comparison of the C<sup>1</sup>XSNPC<sup>2</sup> (hEGF12 complex; <italic>magenta</italic>) and C<sup>1</sup>XSSPC<sup>2</sup> (hF7EGF1 complex; <italic>cyan</italic>) motifs, showing the Xb(Asn/Ser) sidechain hydrogen bonds. For clarity, the Ala172 and Gln240 sidechains are not shown. <bold>c</bold> The five conserved hydrogen bonds. For clarity, the sidechains of variable residues are not shown. <bold>d</bold> Binding surface (<italic>green</italic>) of the C<sup>1</sup>C<sup>2</sup> loop (<italic>purple</italic>) in the POGLUT1/hEGF12/UDP complex. <bold>e</bold> Binding surface (<italic>green</italic>) of the C<sup>2</sup>C<sup>3</sup> loop (<italic>orange</italic>) in the POGLUT1/hEGF12/UDP complex. <italic>i</italic>, <italic>i</italic>â+â1, <italic>i</italic>â+â2, and <italic>i</italic>â+â3 mark the residues involved in the type Iâ Î²-turn. The <italic>i</italic>â+â2 position is a glycine in most other EGF-like domains</p></caption><graphic xlink:href="41467_2017_255_Fig2_HTML" id="d29e832"/></fig>
</p>
        <p id="Par9">Comparison with the dRumi/hF9EGF1/UDP complex<sup><xref ref-type="bibr" rid="CR16">16</xref></sup> shows that the conformation of the hF9EGF1 domain and its glycosylation motif are very similar to that observed here (Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">6</xref>). Moreover, analysis of structures deposited in the PDB show that the conformation of the glucosylation motif is very similar to that found in EGF-like domains in the absence of POGLUT1 (Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">5</xref>), an indication that POGLUT1 does not appreciably distort the acceptor substrate.</p>
      </sec>
      <sec id="Sec5">
        <title>The C<sup>2</sup>C<sup>3</sup> loop is a determinant of POGLUT1 recognition</title>
        <p id="Par10">As we now show, the C<sup>2</sup>C<sup>3</sup> loop of the EGF-like domain, the site of the POFUT1 fucosylation motif (C<sup>2</sup>XXXXS/TC<sup>3</sup>), also serves as a determinant of recognition for POGLUT1. All of the EGF-like domains studied here possess the POFUT1 fucosylation motif and as the structures show, the fucosylatable Ser/Thr residue points to solvent. As such, the fucosylation state of the EGF-like domain would not be expected to significantly modulate its interaction with POGLUT1. The first four residues of the C<sup>2</sup>C<sup>3</sup> loop form a type Iâ² Î²-turn and Loop 2 (residues 170â181) of POGLUT1 interacts with exposed backbone atoms of the first three. Of the five conserved hydrogen bonds between POGLUT1 and the EGF-like domains observed in our complexes, the fifth is between the NH group of the <italic>i</italic>â+â1 residue (C<sup>2</sup>(+2)) of the Î²-turn and the backbone carbonyl oxygen atom of POGLUT1 residue Pro178 (Fig.Â <xref rid="Fig2" ref-type="fig">2c</xref>). Also notable are the interactions made by POGLUT1 residue Trp174 that is sandwiched between Pro175 and the peptide plane formed by the <italic>i</italic>â+â1 and <italic>i</italic>â+â2 residues of the Î²-turn. In the POGLUT1/hEGF12/UDP complex, the presence of the Asp sidechain at the <italic>i</italic>â+â2 position of hEGF12 further extends the interaction surface with Trp174 (Fig.Â <xref rid="Fig2" ref-type="fig">2e</xref>). Interestingly, dRumi possesses a single lysine residue in place of Trp174 and Pro175 and the stacking interaction is not observed. Nevertheless, the hydrogen bond between the NH of the <italic>i</italic>â+â1 residue and Pro178 is observed (Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">6c</xref>). As shown in TableÂ <xref rid="Tab1" ref-type="table">1</xref> and Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">9</xref>, mutation of the 5-residue C<sup>2</sup>C<sup>3</sup> loop of hEGF12 to 4-, 6-, and 7-residues leads to very poor substrates for both POGLUT1 and dRUMI, an indication that interactions with a five-membered C<sup>2</sup>C<sup>3</sup> loop are important in both proteins.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Kinetic parameters of POGLUT1 and dRumi with EGF-like domains and UDP-glucose (UG) or UDP-xylose (UX)</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Enzyme</th><th>Donor</th><th>
<italic>K</italic>
<sub>M</sub>
<sup>a</sup> (Î¼M)</th><th>
<italic>V</italic>
<sub>max</sub>
<sup>a</sup> (Î¼molâmin<sup>â1</sup>âmg<sup>â1</sup>)</th><th>
<italic>n</italic>
</th><th>
<italic>V</italic>
<sub>max</sub>/<italic>K</italic>
<sub>M</sub> (Î¼molâmin<sup>â1</sup>âmg<sup>â1</sup>âÎ¼M<sup>â1</sup>)</th></tr></thead><tbody><tr><td>hF7EGF1 (C<sup>1</sup>A<underline>S</underline>SPC<sup>2</sup>)</td><td>hPOGLUT1</td><td>UG</td><td>0.3âÂ±â0.1</td><td>0.20âÂ±â0.01</td><td>4</td><td>0.59âÂ±â0.08</td></tr><tr><td/><td>hPOGLUT1</td><td>UX</td><td>0.7âÂ±â0.2</td><td>0.19âÂ±â0.01</td><td>3</td><td>0.26âÂ±â0.06</td></tr><tr><td>hEGF12 <italic>wt</italic> (C<sup>1</sup>V<underline>S</underline>NPC<sup>2</sup>)</td><td>hPOGLUT1</td><td>UG</td><td>7.7âÂ±â1.5</td><td>0.18âÂ±â0.02</td><td>6</td><td>0.023âÂ±â0.005</td></tr><tr><td/><td>hPOGLUT1</td><td>UX</td><td>11âÂ±â1</td><td>0.10âÂ±â0.01</td><td>4</td><td>0.009âÂ±â0.001</td></tr><tr><td/><td>dRumi</td><td>UG</td><td>21âÂ±â3</td><td>0.48âÂ±â0.03</td><td>3</td><td>0.022âÂ±â0.003</td></tr><tr><td>hEGF12 N459S (C<sup>1</sup>V<underline>S</underline>SPC<sup>2</sup>)</td><td>hPOGLUT1</td><td>UG</td><td>5.3âÂ±â1.0</td><td>0.19âÂ±â0.01</td><td>5</td><td>0.036âÂ±â0.007</td></tr><tr><td/><td>hPOGLUT1</td><td>UX</td><td>6.6âÂ±â0.8</td><td>0.18âÂ±â0.01</td><td>4</td><td>0.028âÂ±â0.004</td></tr><tr><td>hEGF12 S458T (C<sup>1</sup>V<underline>T</underline>NPC<sup>2</sup>)</td><td>hPOGLUT1</td><td>UG</td><td>No reaction</td><td>0</td><td>3</td><td/></tr><tr><td>hEGF12 4-res C<sup>2</sup>C<sup>3</sup>
</td><td>hPOGLUT1</td><td>UG</td><td>155âÂ±â10</td><td/><td>3</td><td/></tr><tr><td/><td>dRumi</td><td>UG</td><td>160âÂ±â10</td><td/><td>3</td><td/></tr><tr><td>hEGF12 6-res C<sup>2</sup>C<sup>3</sup>
</td><td>hPOGLUT1</td><td>UG</td><td>Very poor (~1âmM)</td><td/><td>3</td><td/></tr><tr><td/><td>dRumi</td><td>UG</td><td>Very poor (~1âmM)</td><td/><td>3</td><td/></tr><tr><td>hEGF12 7-res C<sup>2</sup>C<sup>3</sup>
</td><td>hPOGLUT1</td><td>UG</td><td>Very poor (~1âmM)</td><td/><td>3</td><td/></tr><tr><td/><td>dRumi</td><td>UG</td><td>Very poor (~1âmM)</td><td/><td>3</td><td/></tr><tr><td/><td>hPOGLUT1</td><td>UG</td><td>68âÂ±â10</td><td/><td>3</td><td/></tr><tr><td/><td>hPOGLUT1</td><td>UX</td><td>62âÂ±â9</td><td/><td>3</td><td/></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>In all cases showing standard deviation of <italic>n</italic> repeats</p></table-wrap-foot></table-wrap>
</p>
      </sec>
      <sec id="Sec6">
        <title>POGLUT1 predominantly modifies h-type EGF-like domains</title>
        <p id="Par11">EGF-like domains have been classified into four types and of these the hEGF and cEGF types (6-Cys-type domains) are the most common<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. Strikingly, we found that 93.8% of the <italic>O</italic>-glucosylation motif-containing EGF-like domains are of the hEGF type (Supplementary TableÂ <xref rid="MOESM1" ref-type="media">6</xref>, Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">2a, b</xref>, Supplementary DataÂ <xref rid="MOESM2" ref-type="media">1</xref> and <xref rid="MOESM3" ref-type="media">2</xref>), the only EGF-like domain type found in Notch and its ligands. Moreover, we found that 84% of all hEGF domains possess a five-membered C<sup>2</sup>C<sup>3</sup> loop, a property not shared by the cEGF domains (Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">2d, e</xref>). The prevalence of a five-residue C<sup>2</sup>C<sup>3</sup> loop among hEGF domains is particularly noteworthy given POGLUT1âs preference for a five-residue C<sup>2</sup>C<sup>3</sup> loop and POFUT1âs strict dependence on a C<sup>2</sup>C<sup>3</sup> loop of this length<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. The glycosylation motifs for POGLUT1 and POFUT1 are found in ~25% (Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">2b</xref>) and ~40%<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> of all hEGF domains, respectively, and ~50% of POGLUT1 substrates are also POFUT1 substrates (Supplementary TableÂ <xref rid="MOESM1" ref-type="media">6</xref>), a clear indication that hEGF domains and these enzymes are linked. Indeed, the presence of POFUT1 and hEGF domains has been found to accompany animal evolution<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> and with the exception of a few parasitic organisms (Supplementary TableÂ <xref rid="MOESM1" ref-type="media">5</xref>), we now show that all animal species sequenced also contain POGLUT1/Rumi homologs (Supplementary DataÂ <xref rid="MOESM2" ref-type="media">1</xref> and <xref rid="MOESM3" ref-type="media">2</xref>).</p>
      </sec>
      <sec id="Sec7">
        <title>POGLUT1 complexes with UDP-CH<sub>2</sub>-glucose and UDP-2F-glucose</title>
        <p id="Par12">Repeated attempts to obtain complexes of POGLUT1 with UDP-glucose or UDP-xylose invariably led to structures showing electron density for only the hydrolysis product, UDP. To gain further insight in the mechanism of catalysis and the dual donor substrate specificity shown by POGLUT1, we employed two different donor substrate analogs: (i) UDP-phosphono-glucose (UDP-CH<sub>2</sub>-glucose), a non-hydrolyzable analog<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> and (ii) the slow substrate/inhibitor UDP-2-deoxy-2-fluoro-glucose (UDP-2F-glucose)<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> (Fig.Â <xref rid="Fig3" ref-type="fig">3a</xref>). The structures of ternary complexes of POGLUT1, EGF(+) and each of the analogs were obtained. As shown in Fig.Â <xref rid="Fig3" ref-type="fig">3b</xref> and Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">4</xref>, the POGLUT1/EGF(+)/UDP-CH<sub>2</sub>-glucose complex showed strong electron density for the entire UDP-CH<sub>2</sub>-glucose molecule. With the exception of the Î²-phosphate, the position and conformation of the nucleoside diphosphate moiety of this analog is essentially the same as that of the UDP in all of the UDP-containing ternary complexes. The methylene linker and glucose moieties are well ordered and the 2-, 3-, and 4-hydroxyls of the glucose make hydrogen bonds with backbone atoms of POGLUT1 residues, Val274, Ala275, and Ala276 of the 272â276 turn. The C6-hydroxyl group donates a strong hydrogen bond (2.84âÃ) to a Î²-phosphate oxygen atom and simultaneously accepts a hydrogen bond from the NH group of POGLUT1 residue Phe278 (Fig.Â <xref rid="Fig3" ref-type="fig">3c, d</xref>). Given that the C6 atom also makes a stacking interaction with the sidechain of Phe278, it is clear that the hydroxymethyl group of the glucose moiety plays an important role in recognition by POGLUT1. Arg218 and Arg279 both coordinate both phosphates of the donor substrate analog (Fig.Â <xref rid="Fig3" ref-type="fig">3c</xref>), interactions that in many GT-B glycosyltransferases serve to stabilize the negative charge that develops at the transition state during catalysis. As shown by the complex, the only interaction between the donor and the acceptor substrates is the van der Waals contact between the acceptor hydroxyl and C1 of the donor.<fig id="Fig3"><label>Fig. 3</label><caption><p>Donor substrate analog complexes. <bold>a</bold> The natural donor substrate, UDP-glucose, and the two donor analogs used for co-crystallization. The UDP-2F-glucose was found to be transferred resulting in the POGLUT1/EGF(+)-2F-glucose/UDP complex. <bold>b</bold> Composite omit map (2<italic>mF</italic>oâ<italic>DF</italic>c) of the donor analog found in the 1.80âÃ POGLUT1/EGF(+)/UDP-CH<sub>2</sub>-glucose complex, contoured at 1.50 RMSD (1.10 eâÃ<sup>â3</sup>). A 3âÃ radius electron density mask was applied around the UDP-CH<sub>2</sub>-glucose for clarity. <bold>c</bold> The glucose subsite showing the hydrogen bonds. Two critical Arg residues interacting with both phosphates are also shown. <bold>d</bold> All hydrogen bonds involving the glucose moiety of UDP-CH<sub>2</sub>-glucose. <bold>e</bold> The EGF(+)/UDP-CH<sub>2</sub>-glucose complex showing the two rotamers (gauche (+) and gauche (â)) observed for the serine. <bold>f</bold> Superimposition of hEGF12 with the EGF(+)/UDP-CH<sub>2</sub>-glucose complex aligned on POGLUT1. <bold>g</bold> The S<sub><italic>N</italic></sub>2 catalytic mechanism of POGLUT1. <bold>h</bold> Composite omit map (2<italic>mF</italic>oâ<italic>DF</italic>c) of the 1.31âÃ POGLUT1/EGF(+)-2F-glucose/UDP product complex, contoured at 1.50 RMSD (1.20 eâÃ<sup>â3</sup>). A 3âÃ radius electron density mask was applied around the UDP and the EGF(+)-2F-glucose for clarity. <bold>i</bold> Superimposition of the EGF(+)-2F-glucose (<italic>blue</italic>) product and the UDP-CH<sub>2</sub>-glucose donor analog (<italic>magenta</italic>). <bold>j</bold> Superimposition of the EGF(+)-2F-glucose (<italic>blue</italic>) and glucosylated hF7EGF1 (<italic>pink</italic>; PDB: 1DAN). POGLUT1 residue Phe104 interacts with the conserved aromatic C<sup>4</sup>(â2) residue in all POGLUT1/EGF complexes</p></caption><graphic xlink:href="41467_2017_255_Fig3_HTML" id="d29e1596"/></fig>
</p>
        <p id="Par13">The glycosylatable Ser sidechain of EGF(+) in the POGLUT1/EGF(+)/UDP-CH<sub>2</sub>-glucose complex is found to populate two different rotamers, as is also observed in the POGLUT1/EGF(+)/UDP complex. In the gauche (â) rotamer the serine hydroxyl donates a hydrogen bond to the sidechain of the catalytic base, Asp133, and in the gauche (+) rotamer it makes hydrogen bonds to Arg107 and the EGF-like domain C<sup>1</sup>(â1) backbone carbonyl. When hydrogen bonded to Asp133, the serine hydroxyl is positioned for in-line S<sub><italic>N</italic></sub>2 attack on C1 of the UDP-CH<sub>2</sub>-glucose analog and the structure provides a model for the Michaelis complex for POGLUT1 glucosylation. In both the POGLUT1/hF7EGF1/UDP and POGLUT1/hEGF12/UDP complexes, the serine hydroxyl is found only in the gauche (â) rotamer where it is hydrogen bonded to the sidechain of the catalytic base and positioned for nucleophilic attack (Fig.Â <xref rid="Fig3" ref-type="fig">3eâg</xref>).</p>
        <p id="Par14">The POGLUT1/EGF(+)/UDP-2F-glucose complex showed that the 2F-glucose moiety had been transferred to EGF(+) in the crystal (Fig.Â <xref rid="Fig3" ref-type="fig">3h</xref>). Bond formation and inversion of stereochemistry at C1 resulted in a rotation of the 2F-glucose moiety relative to that of the glucose moiety in the UDP-CH<sub>2</sub>-glucose complex (Fig.Â <xref rid="Fig3" ref-type="fig">3i</xref>). In this orientation/position, none of the hydrogen bonds to the saccharide hydroxyl groups observed in the UDP-CH<sub>2</sub>-glucose complex are observed. Notably, the orientation/position of the 2F-glucose moiety is very similar to that of the glucose moiety found to be transferred in the dRUMI/hF9EGF1-glucose/UDP product complex (PDB ID: 5F84)<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. However, the orientation/position of the transferred 2F-glucose moiety is not that observed in the PDB for the glucose moiety of glucosylated EGF-like domains that are not bound by POGLUT1/Rumi (Fig.Â <xref rid="Fig3" ref-type="fig">3j</xref>).</p>
      </sec>
      <sec id="Sec8">
        <title>The donor substrate site accesses two local conformations</title>
        <p id="Par15">A comparison of the UDP-CH<sub>2</sub>-glucose complex with that of all of the UDP-containing complexes shows that POGLUT1 can access two local conformational states (Fig.Â <xref rid="Fig4" ref-type="fig">4a</xref>). In the UDP-CH<sub>2</sub>-glucose complex, the 272â276 turn of POGLUT1, which interacts with the glucose moiety, has undergone a segmental shift of up to 1âÃ relative to that seen in the UDP complexes. In addition, POGLUT1 residues 212â227, which form a strand-turn-helix, shift up to 2âÃ to enable the sidechain of Arg218 to interact with the Î²-phosphate of the nucleotide sugar. Overall, these conformational changes lead to an increase in the volume of the saccharide subsite of the donor substrate to accommodate the glucose moiety.<fig id="Fig4"><label>Fig. 4</label><caption><p>Two local conformational states of the glucose subsite and docking of UDP-xylose. <bold>a</bold> The UDP-CH<sub>2</sub>-glucose complex (<italic>pink</italic>) compared to the five UDP-bound structures (<italic>light blue</italic>). <bold>b</bold> UDP-xylose docked into the UDP conformation (<italic>light blue</italic>), compared to the UDP-CH<sub>2</sub>-glucose complex (<italic>pink</italic>). <bold>c</bold> Comparison of the binding pocket of the UDP bound state (<italic>left</italic>, showing a docked UDP-xylose) and the UDP-CH<sub>2</sub>-glucose bound state (<italic>right</italic>). <bold>d</bold> Superimposition of the docked UDP-xylose (<italic>blue</italic>), the co-crystallized UDP-CH<sub>2</sub>-glucose (<italic>pink</italic>), and the hF7EGF1 complex (showing the acceptor Ser and the catalytic base Asp133). The two <italic>arrowheads</italic> indicate the direction of nucleophilic attack for glucosylation and xylosylation</p></caption><graphic xlink:href="41467_2017_255_Fig4_HTML" id="d29e1713"/></fig>
</p>
        <p id="Par16">In addition to transferring glucose, POGLUT1 can also transfer xylose<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>, a 5-carbon sugar that differs from glucose only by the lack of the hydroxymethyl group of glucose. As discussed above, the hydroxymethyl group is buried and makes key interactions with POGLUT1 in the UDP-CH<sub>2</sub>-glucose complex, interactions that would not be possible with xylose. Building on the observation that POGLUT1 can access two local conformational states, we explored the possibility that POGLUT1 binds UDP-xylose when it is in its UDP-bound conformation. Indeed, with either SwissDock or AutoDock/AutoDock Vina<sup><xref ref-type="bibr" rid="CR23">23</xref>â<xref ref-type="bibr" rid="CR25">25</xref></sup>, we obtained a compelling model for UDP-xylose binding based on the POGLUT1/hF7EGF1/UDP complex (Fig.Â <xref rid="Fig4" ref-type="fig">4b, c</xref>). The xylose moiety is tilted relative to that observed for the glucose moiety in the POGLUT1/EGF(+)/UDP-CH<sub>2</sub>-glucose complex, but its C2, C3, and C4 hydroxyl groups are hydrogen bonded to the same POGLUT1 groups. The xylose C5 atom, absent the hydroxymethyl group found in glucose, is stacked against POGLUT1 residue Phe278. The C1-O bond of UDP-xylose is well aligned for in-line S<sub><italic>N</italic></sub>2-like attack by the serine hydroxyl of the EGF-like domain (Fig.Â <xref rid="Fig4" ref-type="fig">4d</xref>) and Arg218 and Arg279 both coordinate the Î²-phosphate. Attempts to perform the same docking procedure with UDP-glucose were not successful, an indication that UDP-glucose cannot be accommodated by POGLUT1 when it is in the UDP-bound conformation.</p>
        <p id="Par17">UDP-xylose could also be docked using the POGLUT1/EGF(+)/UDP-CH<sub>2</sub>-glucose complex, although in this case the xylose moiety does not fill the glucose subsite owing to the absence of the hydroxymethyl group (Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">8b</xref>). This UDP-xylose docking model and the one obtained using the POGLUT1/EGF(+)/UDP complex were then subject to all-atom (protein and ligand) energy minimization-repacking calculations using Rosetta<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. The complex based on the latter showed little change after energy minimization, an indication of the quality of the model obtained when UDP-xylose is docked to POGLUT1 in the UDP-bound conformation. In contrast, the model for UDP-xylose binding based on the POGLUT1/EGF(+)/UDP-CH<sub>2</sub>-glucose complex showed significant local change. The xylose moiety moved toward Phe278 and both the 272â276 turn and the Phe278 sidechain of POGLUT1 moved to interact with the xylose to minimize the cavity created by the loss of the hydroxymethyl group (Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">8</xref>). Taken together, docking and energy minimization supports the suggestion that the POGLUT1 conformation observed in the UDP-containing complexes is responsible for UDP-xylose binding/catalysis. However, further structural analysis will be required to validate that this is the case.</p>
      </sec>
      <sec id="Sec9">
        <title>POGLUT1 catalysis and its serine specificity</title>
        <p id="Par18">Unlike other protein-<italic>O</italic>-glycosyltransferases that can glycosylate both serine and threonine, POGLUT1 can only glycosylate serine<sup><xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR27">27</xref></sup> and our structures now provide an explanation for why this is the case. POGLUT1 is an inverting glycosyltransferase, a class of enzymes that typically employ an S<sub><italic>N</italic></sub>2-like mechanism and possess a catalytic base that activates the nucleophilic hydroxyl group of the acceptor substrate<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. As shown in Fig.Â <xref rid="Fig3" ref-type="fig">3eâg</xref>, the hydrogen bond to the POGLUT1 catalytic base, Asp133, fixes the serine hydroxyl of the acceptor substrate in the gauche (â) rotamer (<italic>Ï</italic>1â=ââ70Â°) where it is aligned for nucleophilic attack. Given its main chain conformation (Î¦â=ââ90âÂ±â5Â°, Î¨â=â15âÂ±â5Â°), threonine could not access this rotamer owing to the steric clash that would ensue between its sidechain methyl group and its own carbonyl oxygen atom (Fig.Â <xref rid="Fig5" ref-type="fig">5a</xref>). Indeed, the sidechain rotamer energy landscape clearly excludes the gauche (â) rotamer for a threonine residue with these Î¦/Î¨ angles (Fig.Â <xref rid="Fig5" ref-type="fig">5b</xref>).<fig id="Fig5"><label>Fig. 5</label><caption><p>The structural basis for the serine-specificity of POGLUT1/Rumi. <bold>a</bold> Superimposition of hEGF12 and UDP-CH<sub>2</sub>-glucose. The hypothetical position of the Î³-methyl group of a Thr residue in the gauche (â) rotamer is indicated by <italic>dotted lines</italic>. The minimum distance for either a Ser or a Thr to the UDP-CH<sub>2</sub>-glucose is 4âÃ. <bold>b</bold> Rotamer analysis of Thr at the <italic>O</italic>-glucosylation site. The distances between the Î³-methyl group and the backbone carbonyl group are plotted against the <italic>Ï</italic>1 angles as the <italic>blue curve</italic>. The minimum non-clashing van der Waals distance between a methyl carbon and a carbonyl oxygen atom (3.25âÃ) is indicated by the <italic>red line</italic>. The repulsive energy is plotted as the <italic>orange curve</italic> in Rosetta energy units. The <italic>red</italic> âSerâ indicates the <italic>Ï</italic>1 angles found in the wild-type EGF-like domain complexes. The <italic>magenta</italic> âThrâ indicates the <italic>Ï</italic>1 angle found in the hEGF12(S458T) mutant complex. <bold>c</bold> The crystal structure of the <italic>O</italic>-glucosylation site mutant (S458T; <italic>magenta</italic>) of hEGF12 superimposed on the wild type structure (<italic>blue</italic>). The minimum distance between the co-crystallized UDP and Thr458 is &gt;6âÃ</p></caption><graphic xlink:href="41467_2017_255_Fig5_HTML" id="d29e1867"/></fig>
</p>
        <p id="Par19">To confirm this rationalization, we mutated the <italic>O</italic>-glucosylation site of hEGF12 to a threonine residue (hEGF12:S458T) and measured its ability to be glucosylated and determined its structure in complex with POGLUT1 and UDP. Consistent with the requirement for serine, the threonine mutant was not glucosylated, even at a concentration of 100âÎ¼M (TableÂ <xref rid="Tab1" ref-type="table">1</xref>, Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">9f),</xref> and as shown by the structure, the conformation of the <italic>O</italic>-glucosylation motif was essentially unchanged. However, the threonine sidechain was found in the gauche (+) conformation (<italic>Ï</italic>1â=â66Â°) where it hydrogen bonds to Arg107 of POGLUT1 and the carbonyl oxygen atom of the C<sup>1</sup>(â1) residue of hEGF12. In this rotamer, the threonine hydroxyl group is not positioned for in-line nucleophilic attack and its methyl group makes contact with the sidechain of Asp133, an interaction that shifts the Asp carboxyl group (Fig.Â <xref rid="Fig5" ref-type="fig">5c</xref>) relative to that seen in all of the other complexes.</p>
      </sec>
      <sec id="Sec10">
        <title><italic>O</italic>-xylosylation does not require a diserine-containing motif</title>
        <p id="Par20">Previous work had suggested that POGLUT1 required the presence of a diserine-containing glycosylation motif (C<sup>1</sup>Xa<underline>S</underline>SPC<sup>2</sup>, i.e., an additional serine at the Xb position) for efficient xylosylation<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. Among the EGF-like domains studied here, EGF(+) (C<sup>1</sup>A<underline>S</underline>NPC<sup>2</sup>) and hEGF12 (C<sup>1</sup>V<underline>S</underline>NPC<sup>2</sup>) do not possess a diserine-containing motif, while hF7EGF1 (C<sup>1</sup>A<underline>S</underline>SPC<sup>2</sup>) does. As shown by their UDP complexes, there is little difference between the two EGF-like domain types (Fig.Â <xref rid="Fig2" ref-type="fig">2b</xref>). Moreover, the Xb residue does not make direct or indirect interactions with the donor substrate in either the UDP-CH<sub>2</sub>-glucose complex (Fig.Â <xref rid="Fig6" ref-type="fig">6a</xref>) or our model for UDP-xylose binding. As such, our structures do not provide insight into why a diserine-containing glycosylation motif might be required for xylosylation.<fig id="Fig6"><label>Fig. 6</label><caption><p>A diserine-containing motif does not determine the donor substrate specificity. <bold>a</bold> Superimposition of the C<sup>1</sup>XSNPC<sup>2</sup> (hEGF12; <italic>magenta</italic>) and C<sup>1</sup>XSSPC<sup>2</sup> (hF7EGF1; <italic>green</italic>) motifs and the UDP-CH<sub>2</sub>-glucose complex. The Xb residue that defines a diserine-containing motif is 8âÃ away from the glucose moiety. <bold>b</bold>, <bold>c</bold> Deconvoluted ESI-MS spectra showing quantitative in vitro xylosylation of hEGF12 (<bold>b</bold>) and EGF(+) (<bold>c</bold>) by POGLUT1</p></caption><graphic xlink:href="41467_2017_255_Fig6_HTML" id="d29e1997"/></fig>
</p>
        <p id="Par21">To explore this further, we assayed hEGF12 and EGF(+), substrates lacking diserine, and found that they can both be readily xylosylated (Fig.Â <xref rid="Fig6" ref-type="fig">6b, c</xref>, Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">10</xref>). We also determined the kinetic parameters for hEGF12 and hF7EGF1, for both glucosylation and xylosylation, at saturating concentrations of UDP-glucose and UDP-xylose. A comparison of the <italic>V</italic>
<sub>max</sub> values for all four combinations of donor and acceptor substrates shows that <italic>V</italic>
<sub>max</sub> for the hEGF12/UDP-xylose combination is ~50% lower than that of the other three (TableÂ <xref rid="Tab1" ref-type="table">1</xref>, Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">9</xref>). In addition, we produced the N459S mutant of hEGF12 (C<sup>1</sup>V<underline>S</underline>SPC<sup>2</sup>), designed to introduce a diserine. The <italic>V</italic>
<sub>max</sub> value of this mutant increased (~2-fold) for the xylosylation reaction, to that observed for the others and it did not change appreciably for the glucosylation reaction. Moreover, the <italic>K</italic>
<sub>M</sub> value of this mutant was ~2-fold lower than that of the wild-type acceptor for the xylosylation reaction. Taken together, these results show that <italic>wt</italic> hEGF12 is a substrate for both glucosylation and xylosylation and that mutating its glucosylation motif to introduce a diserine leads to only a modest ~3-fold increase in <italic>V</italic>
<sub>max</sub>/<italic>K</italic>
<sub>M</sub> for the xylosylation reaction. As shown in TableÂ <xref rid="Tab1" ref-type="table">1</xref>, the <italic>K</italic>
<sub>M</sub> values for hF7EGF1 for both glucosylation and xylosylation are considerably lower than that for hEGF12 and the <italic>V</italic>
<sub>max</sub> values for both reactions are similar.</p>
      </sec>
    </sec>
    <sec id="Sec11" sec-type="discussion">
      <title>Discussion</title>
      <p id="Par22">POGLUT1/Rumi recognizes a diverse array of EGF-like domain substrates and can only glucosylate/xylosylate those that are properly folded, properties shared by POFUT1. We now show that for POGLUT1 these properties are a result of an extended shape complementarity as well as interactions with the C<sup>1</sup>C<sup>2</sup> loop (the site of glucosylation/xylosylation), the C<sup>2</sup>C<sup>3</sup> loop (the site of POFUT1 fucosylation), and a conserved aromatic residue at the C<sup>4</sup>(â2) position of the EGF-like domain. Backbone atoms are important in the recognition of both loops and, as such, structural/conformational features common to all of its EGF-like domain substrates play key roles in binding/catalysis. Extensive shape complementarity and interactions with backbone atoms of the O-fucosylation motif (i.e., the C<sup>2</sup>C<sup>3</sup> loop) also characterizes POFUT1âs interactions with its substrates<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, evidence that the two enzymes recognize their EGF-like domain substrates by similar mechanisms.</p>
      <p id="Par23">Unlike most other protein-<italic>O</italic>-glycosyltransferases, POGLUT1 is specific for acceptor substrates with a serine at the site of glycosylation. Contrary to that previously suggested<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, we now show that the serine specificity is a result of well-established mainchainâsidechain steric constraints<sup><xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref></sup>. Given the mainchain conformation of the <italic>O</italic>-glucosylation motif, only serine can access the sidechain rotamer required for activation and in-line nucleophilic attack on C1 of the donor substrate. As such, POGLUT1âs requirement for folded EGF-like domain substrates also leads to its specificity for serine. This is to be contrasted with the large family of polypeptide GalNAc transferases that target flexible or disordered regions of their protein substrates and that can glycosylate either serine or threonine<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>.</p>
      <p id="Par24">Many glycosyltransferases possess loops, often ordered on donor substrate binding, that undergo an orderâdisorder transition during successive catalytic cycles<sup><xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref></sup>. These loops have been proposed to prevent donor substrate hydrolysis, to facilitate acceptor binding, to seal the catalytic site from bulk water and following catalysis, to promote product release. Although ordered in all of our structures and the previously reported <italic>apo</italic> form of dRUMI<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, Loop 1 and Loop 2 of POGLUT1 almost certainly require an orderâdisorder transition to permit substrate binding and product release. POFUT1 is devoid of such loops and as recently shown<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, the EGF-like domain interacts with POFUT1 to form a seal around C1 of the donor substrate that excludes bulk water without the involvement of loops that undergo an orderâdisorder transition. POGLUT1 and POFUT1 recognize different (but overlapping) surfaces on the folded EGF-like domain and these enzymes have clearly evolved a different means of generating the chemical environment required for catalysis. In both cases, however, the acceptor substrate contributes to burying the donor substrate, a stacking arrangement common to glycosyltransferases and that leads to the ordered sequential <italic>Bi-Bi</italic> kinetic mechanism that they typically display.</p>
      <p id="Par25">Although the turnover of a nucleoside diphosphate-2-fluorosugar is not unprecedented<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>, transfer to the acceptor substrate is not typically observed since the inductive effect of the fluorine destabilizes the positively charged transition state sufficiently<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. The observation that 2F-glucose was transferred to EGF(+) in our POGLUT1/EGF(+)/UDP-2F-glucose crystal suggests that either the POGLUT1 transition state develops little positive charge or that even though it is destabilized, the activation energy for catalysis is still relatively low. The structure also provides insight into the process of product release as it represents a snapshot along the reaction coordinate while the 2F-glucose-EGF(+) product is still bound to POGLUT1. The position/orientation of the transferred saccharide moiety in these complexes is not that observed for the glucose moiety in the glucosylated EGF-like domains found in the PDB. In the latter, the glucose moiety interacts with the highly conserved aromatic residue at the C<sup>4</sup>(â2) position that interacts with POGLUT1 in our complexes. It follows that reorientation of the glucose moiety to interact with the C<sup>4</sup>(â2) residue after transfer may serve as a means of promoting release of the glycosylated EGF-like domain.</p>
      <p id="Par26">Previous work had suggested that POGLUT1âs ability to efficiently xylosylate EGF-like domains was dependent on a diserine-containing glycosylation motif<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. We have now shown that POGLUT1 can xylosylate EGF(+) and hEGF12, EGF-like domains that contain an Asn at the Xb position. Moreover, we showed that the introduction of a serine residue at the Xb position in hEGF12 leads to only a modest improvement in <italic>V</italic>
<sub>max</sub>/<italic>K</italic>
<sub>M</sub> for xylosylation. These results are consistent with the observation that the sidechain of the Xb residue interacts with POGLUT1 and does not interact with the donor substrate. The ability to xylosylate hEGF12, an EGF-like domain possessing the C<sup>1</sup>Xa<underline>S</underline>NPC<sup>2</sup> motif found in 36% of POGLUT1 substrates (Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">3</xref>), shows that POGLUT1 has the potential to xylosylate many more EGF-like domains than previously thought. The GXylT-mediated and XXylT-mediated elongation of <italic>O</italic>-glucose moieties play important roles in Notch trafficking and signaling<sup><xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref></sup>. As such, the nature of the roles that the elongation of <italic>O</italic>-xylose might play is an important and open question. Indeed, it has been suggested that the elongation of <italic>O</italic>-xylose on Notch by enzymes involved in GAG synthesis might be possible<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>.</p>
      <p id="Par27">The hydroxymethyl group of the glucose moiety of the donor substrate is buried and makes key hydrogen bonds and van der Waals interactions with POGLUT1. Absent compensatory conformational changes in POGLUT1, the loss of the interactions with the hydroxymethyl group, and the cavity created in its absence, would be expected to destabilize a UDP-xylose complex. Indeed, our structures show that POGLUT1 can assume two local conformational states, the one observed in the UDP-CH<sub>2</sub>-glucose complex and the one observed in all of the UDP-containing complexes. In conjunction with our structural work, docking and energy minimization suggests that binding/reaction of UDP-glucose and UDP-xylose is respectively mediated by these two conformations. We have also shown that <italic>V</italic>
<sub>max</sub>/<italic>K</italic>
<sub>M</sub> values for the acceptor substrates assayed here are similar for the two donor substrates. It is certainly possible that access to conformations that are individually optimal for the binding and reaction of each of them are responsible for the comparable catalytic efficiencies observed. In any case, comparable catalytic efficiencies suggest that the extent to which glucose and xylose are transferred to a given acceptor site will depend on the UDP-glucose and UDP-xylose concentrations in the ER<sup><xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref></sup>.</p>
      <p id="Par28">Proteins such as the Notch receptor possess long tandem repeats of hEGF domains and both the glucosylation and fucosylation of these domains have been found to play roles in their folding, thermal stability and trafficking/secretion<sup><xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR11">11</xref>â<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR35">35</xref></sup>. The importance of these roles is reflected in the fact that the presence of hEGF domains and POFUT1 has accompanied animal evolution<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, a correlation that we now show extends to POGLUT1 with few exceptions. We also find that the C<sup>2</sup>C<sup>3</sup> loop of the hEGF domain, the site of POFUT1 fucosylation, is also recognized by POGLUT1, an observation that may be of significance from an evolutionary standpoint. Among hEGF domains this loop typically contains 5-residues, the optimal length for recognition by both POFUT1 and POGLUT1. The use of a common structural element in this way provides a means of targeting hEGF domains, while minimizing constraints on hEGF domain evolution, and suggests that these enzymes have co-evolved with hEGF domains. Indeed, the shared mechanisms that allow POGLUT1 and POFUT1 to recognize diverse and folded substrates have presumably facilitated the evolution and expansion of hEGF domains and the proteins that contain them.</p>
    </sec>
    <sec id="Sec12" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec13">
        <title>Expression and purification of proteins</title>
        <p id="Par29">The cDNA sequence encoding residues 29â385 of human POGLUT1 (Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">1</xref>) was cloned into the <italic>piggyBac</italic> transposon-based mammalian expression vector PB-T-PAF<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. The resulting construct includes an N-terminal human cystatin S secretion signal<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>, a Protein A domain for affinity purification, a TEV cleavage site, and the hPOGLUT1 domain. The Protein A-POGLUT1 fusion protein was secreted from a stably transfected HEK293S GnTI-cell line (obtained from MIT under a MTA)<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. Cells were scaled-up in DMEM/F12 medium supplemented with 3% (v/v) fetal bovine serum and 1% penicillin-streptomycin. In the production phase, doxycycline was added to a final concentration of 1âÎ¼gâml<sup>â1</sup> to induce the expression of the target protein. The tissue culture medium containing the secreted Protein AâPOGLUT1 fusion protein was concentrated 10-fold and purified by IgG Sepharose affinity chromatography (GE Healthcare, cat. #17-0969-01). On-column cleavage was performed using ~0.1âmgâml<sup>â1</sup> tobacco etch virus (TEV) protease to release the hPOGLUT1 fragment from the IgG beads. The human POGLUT1 fragment expressed contains four <italic>N</italic>-glycosylation sites. The <italic>N</italic>-glycosylated POGLUT1 was deglycosylated by treating the protein with 0.01âmgâmL<sup>â1</sup> EndoH<sup><xref ref-type="bibr" rid="CR41">41</xref></sup> at 4âÂ°C for 24âh. The deglycosylated POGLUT1 was further purified by ion-exchange chromatography on a HiTrap SP sepharose column (GE Healthcare cat. #17-1151-01) and size-exclusion chromatography on a Superdex 200 10/300 column (GE Healthcare, cat. #17-5175-01). The <italic>Drosophila</italic> Rumi (residues 39â406, containing no <italic>N</italic>-glycans) used for enzymatic assays was produced with the same procedure except for the EndoH treatment. For the affinity chromatography and size-exclusion chromatography, the buffers contained 10âmM HEPES (pH 7.0), 250âmM NaCl. The purified hPOGLUT1 and dRumi were stored in 5âmM HEPES buffer (pH 7.0) containing 250âmM NaCl at 4âÂ°C. The cloning primers are listed in Supplementary TableÂ <xref rid="MOESM1" ref-type="media">2</xref>. Protein sequence alignment of hPOGLUT1 with homologs found in representative animal species can be found in Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">1</xref>.</p>
        <p id="Par30">The cDNAs encoding the human Notch1 EGF12 domain and human Factor VII EGF1 domain, and a synthetic sequence, EGF(+), were cloned into the pMAL-p2X vector (New England Biolabs). EGF(+) is a consensus sequence of POFUT1 substrates<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> and it is also a good POGLUT1 substrate. The mutants of EGF-like domains were generated using the In-Fusion HD Cloning System (Clontech cat. #639647). The protein sequences of the EGF-like domains and their mutants are listed in Supplementary TableÂ <xref rid="MOESM1" ref-type="media">3</xref>. The MBP-EGF fusion proteins were produced in the BL21(DE3) strain of <italic>E. coli</italic> by a 3-h induction at 37âÂ°C using 0.25âmM IPTG. The MBP-EGF fusion proteins were then affinity-purified using amylose resin (New England Biolabs, cat. #E8021L). The maltose-eluted MBP-EGF fusion proteins were further purified by ion-exchange chromatography on a HiTrap Q HP column (GE Healthcare cat. #17-1153-01). After TEV cleavage, the free EGF-like domains were separated from the MBP domain by size-exclusion chromatography on a Superdex 75 10/300 GL column (GE Healthcare cat. #17-5174-01) and further purified by ion-exchange chromatography on a HiTrap Q HP column. The free EGF-like domains were then purified by reverse-phase HPLC on a C18 column with an acetonitrile:H<sub>2</sub>O gradient running from 20 to 30% (v/v) in the presence of 0.06% (v/v) trifluoroacetic acid. The EGF-like domains were then concentrated to 2â10âmgâmL<sup>â1</sup> and stored in 5âmM HEPES (pH 7.0), 50âmM NaCl at 4âÂ°C.</p>
      </sec>
      <sec id="Sec14">
        <title>Protein sequence database analysis</title>
        <p id="Par31">The NCBI BLAST non-redundant (nr) protein database contains all known protein sequences and was analyzed using a set of Perl programs, as previously described<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. To avoid sampling bias only organisms with fully sequenced genomes (listed in the NCBI Taxonomy database) were analyzed. Detection of the O-fucosylation motif was based on a search for the C<sup>2</sup>XXXX(S/T)C<sup>3</sup> sequence and the detection of the O-glucosylation motif was based on a search for the C<sup>1</sup>XSXPC<sup>2</sup> motif.</p>
      </sec>
      <sec id="Sec15">
        <title>Crystallization of POGLUT1 complexes</title>
        <p id="Par32">The POGLUT1/EGF complexes with UDP were crystallized using the hanging-drop vapor-diffusion method. Crystals were obtained from 10â20% (v/v) PEG 5000 MME, 50âmM MES pH 6.5, 2â10âmM CaCl<sub>2</sub>, 0â250âmM NaCl, 5â10% (v/v) glycerol or 2-methyl-2,4-pentanediol (MPD), and 1â2âmM UDP. Artificial mother liquors containing 20â25% (v/v) glycerol or 10â20% MPD were used to soak the crystals before freezing in liquid nitrogen. All crystals grew in space group <italic>P</italic>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub>, with one POGLUT1/EGF/UDP complex in the asymmetric unit (Supplementary TableÂ <xref rid="MOESM1" ref-type="media">1</xref>). In an attempt to produce a UDP-glucose or UDP-xylose complex, the <italic>O</italic>-glucosylation site serine of hEGF12, hF7EGF1 and EGF(+) were mutated to alanine. In addition, to limit hydrolysis of the donor substrate, a few different measures were taken, including lowering the crystallization temperature to 4âÂ°C, shortening the crystal growth time to 1âday (with seeding), macro seeding followed by the addition of fresh donor substrate and soaking crystals with 2â5âmM fresh donor substrate prior to crystal harvesting. Despite all of these efforts, in all of the resultant structures we only observed the hydrolysis product UDP in the donor substrate binding site.</p>
        <p id="Par33">The slow substrate/inhibitor, UDP-2F-glucose<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>, and the non-hydrolyzable analog, UDP-CH<sub>2</sub>-glucose<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>, were used in co-crystallization experiments with EGF-like domains containing a glycosylatable serine. The use of UDP-2F-glucose resulted in complete transfer of the 2F-glucose moiety to the EGF(+) domain. By contrast, the UDP-CH<sub>2</sub>-glucose was intact in the crystal structure, leading to a donor substrate analog complex with POGLUT1 and EGF(+).</p>
      </sec>
      <sec id="Sec16">
        <title>Structure determination of the POGLUT1 complexes</title>
        <p id="Par34">The structure of the POGLUT1-EGF complex was solved by the single wavelength anomalous dispersion technique using POGLUT1/EGF(+)/UDP crystals grown in the presence of 0.5âM potassium iodide. The diffraction data were collected at 1.77âÃ on beamline 08ID-1 at the Canadian Light Source. The data set used for phasing was from a single crystal processed to 2.2âÃ resolution. Heavy atom sites were determined using the SHELXD program. Twelve iodide sites were found with occupancy &gt;0.2. The protein phases were calculated using the SHELXE program<sup><xref ref-type="bibr" rid="CR42">42</xref></sup> with an estimated mean Figure of Merit of 0.654 and pseudo-free CC of 68.59%. Both POGLUT1 and EGF(+) were manually built using the program COOT<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. All residues except for residue Gly29 of POGLUT1 and the two N-terminal residues (Gly-Ser) of the EGF(+) construct could be built into the initial map. This structure was refined using the programs REFMAC5<sup><xref ref-type="bibr" rid="CR44">44</xref></sup> and phenix.refine<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> to an <italic>R</italic>
<sub>free</sub> of 0.21 and an <italic>R</italic>
<sub>work</sub> of 0.18.</p>
        <p id="Par35">The native data sets of the POGLUT1/EGF/UDP complexes were collected at 0.98âÃ on beamline 08ID-1 at the Canadian Light Source. The native data sets of the POGLUT1/EGF/UDP-CH<sub>2</sub>-glucose and POGLUT1/EGF-2F-glucose/UDP complexes were collected at 1.00âÃ on beamline 17-ID at the Advanced Photon Source (APS). The native data set of the POGLUT1/hEGF12(S458T)/UDP complex was collected at 1.54âÃ on a Bruker D8-Venture system equipped with a Cu rotating anode X-ray source. All of the native complexes were solved by molecular replacement using the refined POGLUT1 structure from the POGLUT1/EGF(+)/UDP complex as search model. The EGF-like domains were built manually from 2<italic>mF</italic>oâ<italic>DF</italic>c maps. The complexes were built using COOT and refined using REFMAC5 and phenix.refine. The composite omit maps of the EGF-like domains and the UDP or donor analogs can be found in Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">4</xref>. The Dali<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> search result of hPOGLUT1 can be found in Supplementary TableÂ <xref rid="MOESM1" ref-type="media">4</xref>. Structural comparison of hPOGLUT1 with the top Dali search hits can be found in Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">7</xref>.</p>
      </sec>
      <sec id="Sec17">
        <title>Docking of UDP-xylose and UDP-glucose to POGLUT1</title>
        <p id="Par36">The docking of UDP-xylose and UDP-glucose to POGLUT1 was first performed using the SwissDock server (<ext-link ext-link-type="uri" xlink:href="http://www.swissdock.ch/">http://www.swissdock.ch/</ext-link>)<sup><xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR47">47</xref></sup>. POGLUT1 structures in either the UDP-bound conformation or the UDP-CH<sub>2</sub>-glucose-bound conformation were used in the docking searches. The UDP-xylose and UDP-glucose ligands used for docking were supplied by the SwissDock ligand library. As a control, the UDP-CH<sub>2</sub>-glucose molecule was randomized, idealized, and then uploaded to the SwissDock server for docking into the POGLUT1 structures. Using the POGLUT1 structure in the UDP-bound conformation, only UDP-xylose was successfully docked by SwissDock. Using POGLUT1 in the UDP-CH<sub>2</sub>-glucose-bound conformation, UDP-xylose, UDP-glucose and UDP-CH<sub>2</sub>-glucose were all successfully docked.</p>
        <p id="Par37">The docking of UDP-glucose and UDP-xylose to POGLUT1 was then performed again using the AutoDock4 program<sup><xref ref-type="bibr" rid="CR24">24</xref></sup> and the AutoDock Vina program<sup><xref ref-type="bibr" rid="CR25">25</xref></sup> to permit protein sidechain flexibility. Protein sidechains surrounding the UDP-glucose binding pocket were treated as flexible. These programs generated results similar to those obtained with the SwissDock server.</p>
      </sec>
      <sec id="Sec18">
        <title>Optimization of the UDP-xylose docking models</title>
        <p id="Par38">The docking solutions were further optimized by re-docking and all-atom repacking calculations using the Rosetta software suite using a previously reported docking protocol<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. The scoring function settings were not modified from the original protocol. The UDP-xylose docking solutions obtained from SwissDock, AutoDock4, or Autodock Vina were used as the starting point. Both the torsion angles and the overall position of the UDP-xylose molecules were varied in small steps to re-dock them. Then multiple cycles of all-atom repacking and high-resolution docking were carried out before final energy minimization. The backbone and sidechains of all residues within a radius of 10âÃ from any atom in the UDP-xylose molecule were allowed to be flexible. The flexible region was extended along the chain by 5 residues (backbone only). Multiple re-docking and repacking solutions were generated from each original docking solution for comparison.</p>
      </sec>
      <sec id="Sec19">
        <title>Enzyme kinetic assays and mass spectrometry</title>
        <p id="Par39">The enzyme kinetic properties of POGLUT1 were assayed using a continuous spectrophotometric assay that couples the generation of UDP with the conversion of NADH to NAD<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. For the determination of the kinetic properties of the EGF-like domains, each reaction consisted of 50âmM HEPES (pH 7.0), 75âmM NaCl, 75âmM KCl, 20âmM MgCl<sub>2</sub>, 400â1000âÎ¼M phosphoenolpyruvate (Sigma-Aldrich, cat. #P7127), 200â500âÎ¼M NADH (Sigma-Aldrich, cat. #N8129), 75 unit per ml pyruvate kinase (Sigma-Aldrich, cat. #P7768), 75 unit per ml lactate dehydrogenase (Sigma-Aldrich, cat. #L2500), 2.5âmM UDP-glucose (Sigma-Aldrich, cat. #670120), or 2.5âmM UDP-xylose (CarboSouce Services, Complex Carbohydrate Research Center), an appropriate amount of POGLUT1/dRumi and variable amounts of the EGF-like domains (in the form of MBP-fusion proteins) in a total volume of 50 or 100âÎ¼l.</p>
        <p id="Par40">The reactions were carried out in 384-well plates in a temperature-controlled EnSpireÂ® plate reader (PerkinElmer) at 37âÂ°C. The reactions were allowed to proceed for 30â300âmin until the EGF-like domain substrates were completely consumed. The UV absorbance of the reactions at 340ânm was constantly monitored to generate reaction progress curves<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. These curves were then corrected for the rate of NADH oxidation and UDP-glucose hydrolysis obtained from the end-of-reaction region. The corrected reaction progress curves were then fitted to a one-substrate MichaelisâMenten model, assuming that the donor substrate at 2.5âmM concentration saturates the enzyme (<italic>K</italic>
<sub>M</sub>â=â~60âÎ¼M for both UDP-glucose and UDP-xylose as listed in TableÂ <xref rid="Tab1" ref-type="table">1</xref>). Curve fitting was carried out using the program Dynafit<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. For each EGF-like domain, multiple reactions starting at various concentrations were fitted globally and the resulting kinetic parameters (<italic>K</italic>
<sub>M</sub> and <italic>V</italic>
<sub>max</sub>) were generated (TableÂ <xref rid="Tab1" ref-type="table">1</xref>, Supplementary Fig.Â <xref rid="MOESM1" ref-type="media">9</xref>). For the hEGF12 6-res and 7-res C<sup>2</sup>C<sup>3</sup> loop mutants we were unable to start the experiments at concentrations close to their expected <italic>K</italic>
<sub>M</sub> values owing to their greatly reduced affinities to POGLUT1/Rumi. Therefore, errors larger than that suggested by the curve fitting statistics are expected and only approximate values, based on the curve fitting results, were reported in TableÂ <xref rid="Tab1" ref-type="table">1</xref>. For the determination of the <italic>K</italic>
<sub>M</sub> values of UDP-glucose or UDP-xylose, varying concentrations of these donor substrates were incubated with POGLUT1 and 50âÎ¼M EGF(+). The initial velocities of these reactions were fitted to a Michaelis-Menten model to obtain the <italic>K</italic>
<sub>M</sub> values.</p>
        <p id="Par41">To confirm the xylosylated products, 100âÎ¼M EGF(+) or hEGF12 was incubated with 1âmM UDP-xylose and 1âÎ¼M POGLUT1 at 37âÂ°C for 3âh. The EGF-like domains were analyzed by LC-MS (C18 reverse phase) using electrospray ionization mass spectrometry (ESI-MS) on a Waters Xevo G2-S QTof instrument. The data were analyzed and deconvoluted using the program mMass<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>.</p>
      </sec>
      <sec id="Sec20">
        <title>Statistical methods</title>
        <p id="Par42">Each <italic>V</italic>
<sub>max</sub> and <italic>K</italic>
<sub>M</sub> value was generated from three or more independent experiments. The number of experiments (<italic>n</italic>), the average values and the standard deviation values are reported in TableÂ <xref rid="Tab1" ref-type="table">1</xref>.</p>
      </sec>
      <sec id="Sec21">
        <title>Code availability</title>
        <p id="Par43">The programs for extracting and analyzing EGF-like domain sequences are available from the authors on request.</p>
      </sec>
      <sec id="Sec22">
        <title>Data Availability</title>
        <p id="Par44">The data supporting the findings of this study are available within the paper and its supplementary information files, or are available from the corresponding author upon request. The structure coordinates have been deposited at the Protein Data Bank with accession codes 5L0R (POGLUT1/UDP/hEGF12), 5L0S (POGLUT1/UDP/hF7EGF1), 5L0T (POGLUT1/UDP/EGF(+)), 5L0U (POGLUT1/UDP-CH<sub>2</sub>-glucose/EGF(+)), 5L0V (POGLUT1/UDP/EGF(+)-2F-glucose), and 5UB5 (POGLUT1/UDP/hEGF12(S458T)).</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Electronic supplementary material</title>
      <sec id="Sec23">
        <p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41467_2017_255_MOESM1_ESM.pdf"><caption><p>Supplementary Information</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41467_2017_255_MOESM2_ESM.pdf"><caption><p>Supplementary Data 1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41467_2017_255_MOESM3_ESM.xlsx"><caption><p>Supplementary Data 2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41467_2017_255_MOESM4_ESM.pdf"><label>Peer Review File</label><caption><p>Reviewer reports and authors' response from the peer review of this Article at Nature Communications</p></caption></media></supplementary-material>
</p>
      </sec>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Electronic supplementary material</bold>
        </p>
        <p>
<bold>Supplementary Information</bold> accompanies this paper at doi:10.1038/s41467-017-00255-7.</p>
      </fn>
      <fn>
        <p>
<bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>This work was supported by a grant to J.M.R. from the Canadian Institutes of Health Research, Funding Reference Number MOP-125956. We thank the Canadian Macromolecular Crystallography Facility staff for synchrotron data collection. We also thank Dr. Sheila Pimentel-Elardo for collecting the ESI-MS data and Dr. Roland Pfoh for the in-house X-ray data collection.</p>
    </ack>
    <notes notes-type="author-contribution">
      <title>Author contributions</title>
      <p>Z.L. and J.M.R. designed the research. Z.L. carried out the bioinformatic, biochemical, and structural studies. M.F. synthesized the fluorinated and phosphonate UDP-glucose analogs. M.S. and D.Z. provided technical assistance. Z.L. and J.M.R. wrote the manuscript. S.G.W. advised the chemical synthesis and edited the manuscript.</p>
    </notes>
    <notes notes-type="COI-statement">
      <sec id="FPar1">
        <title>Competing interests</title>
        <p id="Par45">The authors declare no competing financial interests.</p>
      </sec>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Teng</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cloning, expression and characterization of a novel human CAP10-like gene hCLP46 from CD34(+) stem/progenitor cells</article-title>
          <source>Gene</source>
          <year>2006</year>
          <volume>371</volume>
          <fpage>7</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="doi">10.1016/j.gene.2005.08.027</pub-id>
          <?supplied-pmid 16524674?>
          <pub-id pub-id-type="pmid">16524674</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Acar</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rumi is a CAP10 domain glycosyltransferase that modifies Notch and is required for Notch signaling</article-title>
          <source>Cell</source>
          <year>2008</year>
          <volume>132</volume>
          <fpage>247</fpage>
          <lpage>258</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2007.12.016</pub-id>
          <?supplied-pmid 18243100?>
          <pub-id pub-id-type="pmid">18243100</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moloney</surname>
              <given-names>DJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mammalian Notch1 is modified with two unusual forms of O-linked glycosylation found on epidermal growth factor-like modules</article-title>
          <source>J. Biol. Chem.</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>9604</fpage>
          <lpage>9611</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.275.13.9604</pub-id>
          <?supplied-pmid 10734111?>
          <pub-id pub-id-type="pmid">10734111</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fernandez-Valdivia</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Regulation of mammalian Notch signaling and embryonic development by the protein O-glucosyltransferase Rumi</article-title>
          <source>Development</source>
          <year>2011</year>
          <volume>138</volume>
          <fpage>1925</fpage>
          <lpage>1934</lpage>
          <pub-id pub-id-type="doi">10.1242/dev.060020</pub-id>
          <?supplied-pmid 21490058?>
          <pub-id pub-id-type="pmid">21490058</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haltom</surname>
              <given-names>AR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The protein O-glucosyltransferase Rumi modifies eyes shut to promote rhabdomere separation in Drosophila</article-title>
          <source>PLoS Genet.</source>
          <year>2014</year>
          <volume>10</volume>
          <fpage>e1004795</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.1004795</pub-id>
          <?supplied-pmid 25412384?>
          <pub-id pub-id-type="pmid">25412384</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramkumar</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Protein O-glucosyltransferase 1 (POGLUT1) promotes mouse gastrulation through modification of the apical polarity protein CRUMBS2</article-title>
          <source>PLoS Genet.</source>
          <year>2015</year>
          <volume>11</volume>
          <fpage>e1005551</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.1005551</pub-id>
          <?supplied-pmid 26496195?>
          <pub-id pub-id-type="pmid">26496195</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Basmanav</surname>
              <given-names>FB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in POGLUT1, encoding protein O-glucosyltransferase 1, cause autosomal-dominant dowling-degos disease</article-title>
          <source>Am. J. Hum. Genet.</source>
          <year>2014</year>
          <volume>94</volume>
          <fpage>135</fpage>
          <lpage>143</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajhg.2013.12.003</pub-id>
          <?supplied-pmid 24387993?>
          <pub-id pub-id-type="pmid">24387993</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Servian-Morilla</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A POGLUT1 mutation causes a muscular dystrophy with reduced Notch signaling and satellite cell loss</article-title>
          <source>EMBO Mol. Med.</source>
          <year>2016</year>
          <volume>8</volume>
          <fpage>1289</fpage>
          <lpage>1309</lpage>
          <pub-id pub-id-type="doi">10.15252/emmm.201505815</pub-id>
          <?supplied-pmid 27807076?>
          <pub-id pub-id-type="pmid">27807076</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Spellman</surname>
              <given-names>MW</given-names>
            </name>
          </person-group>
          <article-title>Purification and characterization of a GDP-fucose:polypeptide fucosyltransferase from Chinese hamster ovary cells</article-title>
          <source>J. Biol. Chem.</source>
          <year>1998</year>
          <volume>273</volume>
          <fpage>8112</fpage>
          <lpage>8118</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.273.14.8112</pub-id>
          <?supplied-pmid 9525914?>
          <pub-id pub-id-type="pmid">9525914</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takeuchi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kantharia</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sethi</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Bakker</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Haltiwanger</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Site-specific O-glucosylation of the epidermal growth factor-like (EGF) repeats of notch: efficiency of glycosylation is affected by proper folding and amino acid sequence of individual EGF repeats</article-title>
          <source>J. Biol. Chem.</source>
          <year>2012</year>
          <volume>287</volume>
          <fpage>33934</fpage>
          <lpage>33944</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M112.401315</pub-id>
          <?supplied-pmid 22872643?>
          <pub-id pub-id-type="pmid">22872643</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vasudevan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Haltiwanger</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Novel roles for O-linked glycans in protein folding</article-title>
          <source>Glycoconj. J.</source>
          <year>2014</year>
          <volume>31</volume>
          <fpage>417</fpage>
          <lpage>426</lpage>
          <pub-id pub-id-type="doi">10.1007/s10719-014-9556-4</pub-id>
          <?supplied-pmid 25186198?>
          <pub-id pub-id-type="pmid">25186198</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haltom</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Jafar-Nejad</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The multiple roles of epidermal growth factor repeat O-glycans in animal development</article-title>
          <source>Glycobiology</source>
          <year>2015</year>
          <volume>25</volume>
          <fpage>1027</fpage>
          <lpage>1042</lpage>
          <pub-id pub-id-type="doi">10.1093/glycob/cwv052</pub-id>
          <?supplied-pmid 26175457?>
          <pub-id pub-id-type="pmid">26175457</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leonardi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fernandez-Valdivia</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>YD</given-names>
            </name>
            <name>
              <surname>Simcox</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Jafar-Nejad</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Multiple O-glucosylation sites on Notch function as a buffer against temperature-dependent loss of signaling</article-title>
          <source>Development</source>
          <year>2011</year>
          <volume>138</volume>
          <fpage>3569</fpage>
          <lpage>3578</lpage>
          <pub-id pub-id-type="doi">10.1242/dev.068361</pub-id>
          <?supplied-pmid 21771811?>
          <pub-id pub-id-type="pmid">21771811</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takeuchi</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rumi functions as both a protein O-glucosyltransferase and a protein O-xylosyltransferase</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2011</year>
          <volume>108</volume>
          <fpage>16600</fpage>
          <lpage>16605</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1109696108</pub-id>
          <?supplied-pmid 21949356?>
          <pub-id pub-id-type="pmid">21949356</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Moloney</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Haltiwanger</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>O-glycosylation of EGF repeats: identification and initial characterization of a UDP-glucose: protein O-glucosyltransferase</article-title>
          <source>Glycobiology</source>
          <year>2002</year>
          <volume>12</volume>
          <fpage>763</fpage>
          <lpage>770</lpage>
          <pub-id pub-id-type="doi">10.1093/glycob/cwf085</pub-id>
          <?supplied-pmid 12460944?>
          <pub-id pub-id-type="pmid">12460944</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Structural analysis of Notch-regulating Rumi reveals basis for pathogenic mutations</article-title>
          <source>Nat. Chem. Biol.</source>
          <year>2016</year>
          <volume>12</volume>
          <fpage>735</fpage>
          <lpage>740</lpage>
          <pub-id pub-id-type="doi">10.1038/nchembio.2135</pub-id>
          <?supplied-pmid 27428513?>
          <pub-id pub-id-type="pmid">27428513</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Recognition of EGF-like domains by the Notch-modifying Oâfucosyltransferase POFUT1</article-title>
          <source>Nat. Chem. Biol.</source>
          <year>2017</year>
          <volume>13</volume>
          <fpage>757</fpage>
          <lpage>763</lpage>
          <pub-id pub-id-type="doi">10.1038/nchembio.2381</pub-id>
          <?supplied-pmid 28530709?>
          <pub-id pub-id-type="pmid">28530709</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coutinho</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Deleury</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Henrissat</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>An evolving hierarchical family classification for glycosyltransferases</article-title>
          <source>J. Mol. Biol.</source>
          <year>2003</year>
          <volume>328</volume>
          <fpage>307</fpage>
          <lpage>317</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-2836(03)00307-3</pub-id>
          <?supplied-pmid 12691742?>
          <pub-id pub-id-type="pmid">12691742</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lawrence</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Colman</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>Shape complementarity at protein/protein interfaces</article-title>
          <source>J. Mol. Biol.</source>
          <year>1993</year>
          <volume>234</volume>
          <fpage>946</fpage>
          <lpage>950</lpage>
          <pub-id pub-id-type="doi">10.1006/jmbi.1993.1648</pub-id>
          <?supplied-pmid 8263940?>
          <pub-id pub-id-type="pmid">8263940</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wouters</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evolution of distinct EGF domains with specific functions</article-title>
          <source>Protein Sci.</source>
          <year>2005</year>
          <volume>14</volume>
          <fpage>1091</fpage>
          <lpage>1103</lpage>
          <pub-id pub-id-type="doi">10.1110/ps.041207005</pub-id>
          <?supplied-pmid 15772310?>
          <pub-id pub-id-type="pmid">15772310</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morgan</surname>
              <given-names>JL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Observing cellulose biosynthesis and membrane translocation in crystallo</article-title>
          <source>Nature</source>
          <year>2016</year>
          <volume>531</volume>
          <fpage>329</fpage>
          <lpage>334</lpage>
          <pub-id pub-id-type="doi">10.1038/nature16966</pub-id>
          <?supplied-pmid 26958837?>
          <pub-id pub-id-type="pmid">26958837</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gibson</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Tarling</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Withers</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>The donor subsite of trehalose-6-phosphate synthase: binary complexes with UDP-glucose and UDP-2-deoxy-2-fluoro-glucose at 2 A resolution</article-title>
          <source>J. Biol. Chem.</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>1950</fpage>
          <lpage>1955</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M307643200</pub-id>
          <?supplied-pmid 14570926?>
          <pub-id pub-id-type="pmid">14570926</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grosdidier</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zoete</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Michielin</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>SwissDock, a protein-small molecule docking web service based on EADock DSS</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2011</year>
          <volume>39</volume>
          <fpage>W270</fpage>
          <lpage>W277</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkr366</pub-id>
          <?supplied-pmid 21624888?>
          <pub-id pub-id-type="pmid">21624888</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morris</surname>
              <given-names>GM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility</article-title>
          <source>J. Comput. Chem.</source>
          <year>2009</year>
          <volume>30</volume>
          <fpage>2785</fpage>
          <lpage>2791</lpage>
          <pub-id pub-id-type="doi">10.1002/jcc.21256</pub-id>
          <?supplied-pmid 19399780?>
          <pub-id pub-id-type="pmid">19399780</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trott</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</article-title>
          <source>J. Comput. Chem.</source>
          <year>2010</year>
          <volume>31</volume>
          <fpage>455</fpage>
          <lpage>461</lpage>
          <?supplied-pmid 19499576?>
          <pub-id pub-id-type="pmid">19499576</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lemmon</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Meiler</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Rosetta ligand docking with flexible XML protocols</article-title>
          <source>Methods Mol. Biol.</source>
          <year>2012</year>
          <volume>819</volume>
          <fpage>143</fpage>
          <lpage>155</lpage>
          <pub-id pub-id-type="doi">10.1007/978-1-61779-465-0_10</pub-id>
          <?supplied-pmid 22183535?>
          <pub-id pub-id-type="pmid">22183535</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rana</surname>
              <given-names>NA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>O-glucose trisaccharide is present at high but variable stoichiometry at multiple sites on mouse Notch1</article-title>
          <source>J. Biol. Chem.</source>
          <year>2011</year>
          <volume>286</volume>
          <fpage>31623</fpage>
          <lpage>31637</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M111.268243</pub-id>
          <?supplied-pmid 21757702?>
          <pub-id pub-id-type="pmid">21757702</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lairson</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Henrissat</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Withers</surname>
              <given-names>SG</given-names>
            </name>
          </person-group>
          <article-title>Glycosyltransferases: structures, functions, and mechanisms</article-title>
          <source>Annu. Rev. Biochem.</source>
          <year>2008</year>
          <volume>77</volume>
          <fpage>521</fpage>
          <lpage>555</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.biochem.76.061005.092322</pub-id>
          <?supplied-pmid 18518825?>
          <pub-id pub-id-type="pmid">18518825</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dunbrack</surname>
              <given-names>RL</given-names>
              <suffix>Jr.</suffix>
            </name>
            <name>
              <surname>Karplus</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Backbone-dependent rotamer library for proteins. Application to side-chain prediction</article-title>
          <source>J. Mol. Biol.</source>
          <year>1993</year>
          <volume>230</volume>
          <fpage>543</fpage>
          <lpage>574</lpage>
          <pub-id pub-id-type="doi">10.1006/jmbi.1993.1170</pub-id>
          <?supplied-pmid 8464064?>
          <pub-id pub-id-type="pmid">8464064</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shapovalov</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Dunbrack</surname>
              <given-names>RL</given-names>
              <suffix>Jr.</suffix>
            </name>
          </person-group>
          <article-title>A smoothed backbone-dependent rotamer library for proteins derived from adaptive kernel density estimates and regressions</article-title>
          <source>Structure</source>
          <year>2011</year>
          <volume>19</volume>
          <fpage>844</fpage>
          <lpage>858</lpage>
          <pub-id pub-id-type="doi">10.1016/j.str.2011.03.019</pub-id>
          <?supplied-pmid 21645855?>
          <pub-id pub-id-type="pmid">21645855</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bennett</surname>
              <given-names>EP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family</article-title>
          <source>Glycobiology</source>
          <year>2012</year>
          <volume>22</volume>
          <fpage>736</fpage>
          <lpage>756</lpage>
          <pub-id pub-id-type="doi">10.1093/glycob/cwr182</pub-id>
          <?supplied-pmid 22183981?>
          <pub-id pub-id-type="pmid">22183981</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qasba</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Ramakrishnan</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Boeggeman</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Substrate-induced conformational changes in glycosyltransferases</article-title>
          <source>Trends Biochem. Sci.</source>
          <year>2005</year>
          <volume>30</volume>
          <fpage>53</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tibs.2004.11.005</pub-id>
          <?supplied-pmid 15653326?>
          <pub-id pub-id-type="pmid">15653326</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Breton</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Snajdrova</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Jeanneau</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Koca</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Imberty</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Structures and mechanisms of glycosyltransferases</article-title>
          <source>Glycobiology</source>
          <year>2006</year>
          <volume>16</volume>
          <fpage>29R</fpage>
          <lpage>37R</lpage>
          <pub-id pub-id-type="doi">10.1093/glycob/cwj016</pub-id>
          <?supplied-pmid 16037492?>
          <pub-id pub-id-type="pmid">16049187</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>TV</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Negative regulation of notch signaling by xylose</article-title>
          <source>PLoS Genet.</source>
          <year>2013</year>
          <volume>9</volume>
          <fpage>e1003547</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.1003547</pub-id>
          <?supplied-pmid 23754965?>
          <pub-id pub-id-type="pmid">23754965</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsumoto</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dual roles of O-glucose glycans redundant with Monosaccharide O-fucose on Notch in Notch trafficking</article-title>
          <source>J. Biol. Chem.</source>
          <year>2016</year>
          <volume>291</volume>
          <fpage>13743</fpage>
          <lpage>13752</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M115.710483</pub-id>
          <?supplied-pmid 27129198?>
          <pub-id pub-id-type="pmid">27129198</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bakker</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functional UDP-xylose transport across the endoplasmic reticulum/Golgi membrane in a Chinese hamster ovary cell mutant defective in UDP-xylose Synthase</article-title>
          <source>J. Biol. Chem.</source>
          <year>2009</year>
          <volume>284</volume>
          <fpage>2576</fpage>
          <lpage>2583</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M804394200</pub-id>
          <?supplied-pmid 19028698?>
          <pub-id pub-id-type="pmid">19028698</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakajima</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Simultaneous determination of nucleotide sugars with ion-pair reversed-phase HPLC</article-title>
          <source>Glycobiology</source>
          <year>2010</year>
          <volume>20</volume>
          <fpage>865</fpage>
          <lpage>871</lpage>
          <pub-id pub-id-type="doi">10.1093/glycob/cwq044</pub-id>
          <?supplied-pmid 20371511?>
          <pub-id pub-id-type="pmid">20371511</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Michael</surname>
              <given-names>IP</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Nagy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rini</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Simple piggyBac transposon-based mammalian cell expression system for inducible protein production</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2013</year>
          <volume>110</volume>
          <fpage>5004</fpage>
          <lpage>5009</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1218620110</pub-id>
          <?supplied-pmid 23476064?>
          <pub-id pub-id-type="pmid">23476064</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barash</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Human secretory signal peptide description by hidden Markov model and generation of a strong artificial signal peptide for secreted protein expression</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <year>2002</year>
          <volume>294</volume>
          <fpage>835</fpage>
          <lpage>842</lpage>
          <pub-id pub-id-type="doi">10.1016/S0006-291X(02)00566-1</pub-id>
          <?supplied-pmid 12061783?>
          <pub-id pub-id-type="pmid">12061783</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reeves</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Callewaert</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Contreras</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Khorana</surname>
              <given-names>HG</given-names>
            </name>
          </person-group>
          <article-title>Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>13419</fpage>
          <lpage>13424</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.212519299</pub-id>
          <?supplied-pmid 12370423?>
          <pub-id pub-id-type="pmid">12370423</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robbins</surname>
              <given-names>PW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary structure of the Streptomyces enzyme endo-beta-N-acetylglucosaminidase H</article-title>
          <source>J. Biol. Chem.</source>
          <year>1984</year>
          <volume>259</volume>
          <fpage>7577</fpage>
          <lpage>7583</lpage>
          <?supplied-pmid 6429133?>
          <pub-id pub-id-type="pmid">6429133</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sheldrick</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>A short history of SHELX</article-title>
          <source>Acta Crystallogr. A</source>
          <year>2008</year>
          <volume>64</volume>
          <fpage>112</fpage>
          <lpage>122</lpage>
          <pub-id pub-id-type="doi">10.1107/S0108767307043930</pub-id>
          <?supplied-pmid 18156677?>
          <pub-id pub-id-type="pmid">18156677</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Emsley</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lohkamp</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Cowtan</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Features and development of Coot</article-title>
          <source>Acta Crystallogr. D Biol. Crystallogr.</source>
          <year>2010</year>
          <volume>66</volume>
          <fpage>486</fpage>
          <lpage>501</lpage>
          <pub-id pub-id-type="doi">10.1107/S0907444910007493</pub-id>
          <?supplied-pmid 20383002?>
          <pub-id pub-id-type="pmid">20383002</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murshudov</surname>
              <given-names>GN</given-names>
            </name>
            <name>
              <surname>Vagin</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Dodson</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>Refinement of macromolecular structures by the maximum-likelihood method</article-title>
          <source>Acta Crystallogr. D Biol. Crystallogr.</source>
          <year>1997</year>
          <volume>53</volume>
          <fpage>240</fpage>
          <lpage>255</lpage>
          <pub-id pub-id-type="doi">10.1107/S0907444996012255</pub-id>
          <?supplied-pmid 15299926?>
          <pub-id pub-id-type="pmid">15299926</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adams</surname>
              <given-names>PD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PHENIX: a comprehensive Python-based system for macromolecular structure solution</article-title>
          <source>Acta Crystallogr. D Biol. Crystallogr.</source>
          <year>2010</year>
          <volume>66</volume>
          <fpage>213</fpage>
          <lpage>221</lpage>
          <pub-id pub-id-type="doi">10.1107/S0907444909052925</pub-id>
          <?supplied-pmid 20124702?>
          <pub-id pub-id-type="pmid">20124702</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Holm</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Rosenstrom</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Dali server: conservation mapping in 3D</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2010</year>
          <volume>38</volume>
          <fpage>W545</fpage>
          <lpage>W549</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkq366</pub-id>
          <?supplied-pmid 20457744?>
          <pub-id pub-id-type="pmid">20457744</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grosdidier</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zoete</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Michielin</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Fast docking using the CHARMM force field with EADock DSS</article-title>
          <source>J. Comput. Chem.</source>
          <year>2011</year>
          <volume>32</volume>
          <fpage>2149</fpage>
          <lpage>2159</lpage>
          <pub-id pub-id-type="doi">10.1002/jcc.21797</pub-id>
          <?supplied-pmid 21541955?>
          <pub-id pub-id-type="pmid">21541955</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gosselin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Alhussaini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Streiff</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Takabayashi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Palcic</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>A continuous spectrophotometric assay for glycosyltransferases</article-title>
          <source>Anal. Biochem.</source>
          <year>1994</year>
          <volume>220</volume>
          <fpage>92</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="doi">10.1006/abio.1994.1303</pub-id>
          <?supplied-pmid 7978262?>
          <pub-id pub-id-type="pmid">7978262</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duggleby</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>Analysis of enzyme progress curves by nonlinear regression</article-title>
          <source>Methods Enzymol.</source>
          <year>1995</year>
          <volume>249</volume>
          <fpage>61</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="doi">10.1016/0076-6879(95)49031-0</pub-id>
          <?supplied-pmid 7791628?>
          <pub-id pub-id-type="pmid">7791628</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuzmic</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase</article-title>
          <source>Anal. Biochem.</source>
          <year>1996</year>
          <volume>237</volume>
          <fpage>260</fpage>
          <lpage>273</lpage>
          <pub-id pub-id-type="doi">10.1006/abio.1996.0238</pub-id>
          <?supplied-pmid 8660575?>
          <pub-id pub-id-type="pmid">8660575</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Strohalm</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kavan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Novak</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Volny</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Havlicek</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>mMass 3: a cross-platform software environment for precise analysis of mass spectrometric data</article-title>
          <source>Anal. Chem.</source>
          <year>2010</year>
          <volume>82</volume>
          <fpage>4648</fpage>
          <lpage>4651</lpage>
          <pub-id pub-id-type="doi">10.1021/ac100818g</pub-id>
          <?supplied-pmid 20465224?>
          <pub-id pub-id-type="pmid">20465224</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>